VanEck Pharmaceutical ETF (PPH) est une société cotée en bourse dans le Services Financiers secteur, opérant dans le Asset Management secteur d'activité.
PPH a date d'introduction en bourse 2000-02-01, cotée sur le NASDAQ Global Market, une capitalisation boursière de $610.23M.
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.